Announcing the GTI-MD. An abridged clinical outcome assessment for measuring steroid-toxicity

Recorded webinar registration

The Glucocorticoid Toxicity Index Metabolic Domains (GTI-MD) is an abridged version of the parent Glucocorticoid Toxicity Index (GTI), which is now deployed in 20 disease indications in 80 countries across the world. The GTI-MD uses an easy to measure, highly-quantitative subset of domains to measure change in steroid-toxicity over time. These domains correlate highly with the parent GTI, and may be deployed easily in settings beyond clinical trials, including large datasets and patient use.   


Join John H. Stone, MD MPH for a presentation covering:
  • The GTI-MD development.
  • Correlation between the GTI-MD and the GTI.
  • The GTI-MD and regulatory strategy.
  • Use of the GTI-MD at point of care.
  • The GTI-MD as a tool for exploring toxicity in large data sets.